Wellstat Therapeutics Corporation
Biotechnology ResearchMaryland, United States11-50 Employees
Wellstat Therapeutics Corporation is a biotechnology company based out of 930 Clopper Rd, Gaithersburg, Maryland, United States.
Recent Asset Sale Wellstat Therapeutics recently divested two key medicines, Vistogard and Xuriden, indicating a strategic shift that may open opportunities to collaborate on new or alternative therapeutic products.
Niche Focus As a small biotechnology firm with a revenue of up to 10 million dollars, Wellstat may be seeking partnerships or clients for specialized biotech solutions or research services tailored to rare or life-saving medicines.
Partnership Potential Given their recent asset sale to SERB Pharmaceuticals, there is potential for future licensing, joint development, or supply agreements, especially considering their expertise in critical pharmaceuticals.
Tech Stack Utilization With a modern technology infrastructure including JSON-LD, HTTP/3, and cloud services, Wellstat is positioned to efficiently support innovative research collaborations and digital health solutions.
Market Positioning Operating in a competitive biotech landscape with companies like Bristol-Myers Squibb and Sanofi, Wellstat offers opportunities for niche contract manufacturing, research partnerships, or specialized product distribution.
Wellstat Therapeutics Corporation uses 8 technology products and services including Open Graph, JSON-LD, Choices, and more. Explore Wellstat Therapeutics Corporation's tech stack below.
| Wellstat Therapeutics Corporation Email Formats | Percentage |
| FLast@wellstattherapeutics.com | 47% |
| First.Last@wellstattherapeutics.com | 3% |
| FLast@wellstattherapeutics.com | 47% |
| First.Last@wellstattherapeutics.com | 3% |
Biotechnology ResearchMaryland, United States11-50 Employees
Wellstat Therapeutics Corporation is a biotechnology company based out of 930 Clopper Rd, Gaithersburg, Maryland, United States.
Wellstat Therapeutics Corporation's revenue is estimated to be in the range of $1M$10M
Wellstat Therapeutics Corporation's revenue is estimated to be in the range of $1M$10M